Illumina appoints Michael Sullivan Chief Commercial Officer and Julie Coletti Chief Legal Officer
Article excerpt
Highlighted: the sentence this signal was extracted from
New leaders bring extensive leadership experience across life sciences, diagnostics, and medical technology SAN DIEGO, July 9, 2026 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the appointment of Mike Sullivan as Chief Commercial Officer, effective July 20, 2026, and Julie Coletti as Chief Legal Officer, effective August 3, 2026. The appointments add experienced leaders to Illumina's Executive Leadership Team as the company continues advancing its strategy, serving customers, driving growth, and delivering on its mission to improve human health around the world. "We are excited to welcome Mike and Julie to Illumina," said Jacob Thaysen, chief executive officer of Illumina. "Mike brings deep commercial expertise, a customer-first mindset, and significant experience scaling global organizations, while Julie is a highly accomplished legal and business leader with deep experience across the life sciences and medical technology sectors. I look forward to working closely with both of them as we continue helping customers unlock new insights across genomics, multiomics, and human health." Sullivan will be responsible for leading Illumina's global commercial organization. He brings more than 30 years of commercial leadership experience across diagnostics, precision medicine, healthcare, and life sciences, with a proven track record of driving growth, expanding...
Keep reading with a free account
The rest of this article, and every signal for Illumina, is in your free account.